These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6673458)

  • 21. Carbenoxolone sodium for gastric ulcer.
    Med Lett Drugs Ther; 1975 Aug; 17(16):67-8. PubMed ID: 1097883
    [No Abstract]   [Full Text] [Related]  

  • 22. The pathogenesis of pseudohyperaldosteronism from carbenoxolone.
    Armanini D; Scali M; Zennaro MC; Karbowiak I; Wallace C; Lewicka S; Vecsei P; Mantero F
    J Endocrinol Invest; 1989 May; 12(5):337-41. PubMed ID: 2671110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy of peptic ulcer with cytoprotective substances].
    Fortunat W
    Wien Med Wochenschr; 1983; 133(4-5):94-8. PubMed ID: 6407215
    [No Abstract]   [Full Text] [Related]  

  • 24. The effectiveness of carbenoxolone in the treatment of gastro-duodenal ulcer patients.
    Loginov AS; Speransky MD; Speranskaya IE; Vasilyev UV; Alecseev VF
    Scand J Gastroenterol Suppl; 1980; 65():85-91. PubMed ID: 7010530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Controlled clinical study of the effectiveness of a new anti-ulcer drug: thiopropamine].
    Masoero G
    Clin Ter; 1979 Aug; 90(3):261-72. PubMed ID: 399873
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of carbenoxolone on gastric release of prostaglandin (PG)E2 in patients with peptic ulcer disease.
    Rask-Madsen J; Bukhave K; Madsen PE; Bekker C
    Acta Gastroenterol Belg; 1983; 46(9-10):419-28. PubMed ID: 6585111
    [No Abstract]   [Full Text] [Related]  

  • 27. The influence of amiloride on the therapeutic and metabolic effects of carbenoxolone in patients with gastric ulcer. A double-blind controlled trial.
    Reed PI; Lewis SI; Vincent-Brown A; Holdstock DJ; Gribble RJ; Murgatroyd RE; Baron JH
    Scand J Gastroenterol Suppl; 1980; 65():51-7. PubMed ID: 7010528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbenoxolone patients with gastric ulcers. A double-blind trial.
    Schwamberger K; Reissigl H
    Scand J Gastroenterol Suppl; 1980; 65():59-62. PubMed ID: 7010529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of carbenoxolone sodium in the treatment of duodenal ulcer.
    Nagy GS
    Gastroenterology; 1978 Jan; 74(1):7-10. PubMed ID: 336453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quiz of month: question 2.
    Campese VM
    Am J Nephrol; 1983; 3(5):285, 295. PubMed ID: 6638087
    [No Abstract]   [Full Text] [Related]  

  • 31. [Carbenoxolone in the treatment of duodenal ulcer].
    Kadish U; Neeman A
    Harefuah; 1979 Sep; 97(5-6):111-2. PubMed ID: 540839
    [No Abstract]   [Full Text] [Related]  

  • 32. Importance of defensive factors in the prevention of peptic ulcer recurrence. Role of carbenoxolone sodium.
    Guslandi M
    Acta Gastroenterol Belg; 1983; 46(9-10):411-8. PubMed ID: 6673456
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of pirenzepine and carbenoxolone in the treatment of chronic gastric ulcer. A double-blind endoscopic trial.
    Bianchi Porro G; Petrillo M; Lazzaroni M; Mazzacca G; Sabbatini F; Piai G; Dobrilla G; De Pretis G; Daniotti S
    Hepatogastroenterology; 1985 Dec; 32(6):293-5. PubMed ID: 3912314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chewing gum and hypokalaemia.
    Rosseel M; Schoors D
    Lancet; 1993 Jan; 341(8838):175. PubMed ID: 8093767
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hypocalcemia during cimetidine and carbenoxolone treatment].
    Beccari G; Del Noce A; Grossi E
    Minerva Med; 1982 Jun; 73(27):1903. PubMed ID: 7088404
    [No Abstract]   [Full Text] [Related]  

  • 36. Cytoprotective therapy of gastric ulcers: a controlled clinical evaluation of triletide versus carbenoxolone.
    Campisi D; Cataldo MG; Paterna S; Bivona A; Barbarino C
    Pharmatherapeutica; 1985; 4(3 Spec No):166-70. PubMed ID: 3903785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The biochemical pharmacology of carbenoxolone. Its possible mechanisms of action.
    Parke DV
    Acta Gastroenterol Belg; 1983; 46(9-10):437-47. PubMed ID: 6369855
    [No Abstract]   [Full Text] [Related]  

  • 38. [Undesirable effects of carbenoxolone treatment in patients with ulcus ventriculi].
    Henrichsen L; Pedersen H; Jensen KB; Wulff HR
    Ugeskr Laeger; 1976 Dec; 138(51):3265-7. PubMed ID: 793123
    [No Abstract]   [Full Text] [Related]  

  • 39. Carbenoxolone induced hypokalemia and ventricular tachycardia--report of a case.
    Lin CS; Wang SS
    Taiwan Yi Xue Hui Za Zhi; 1978 Apr; 77(4):418-22. PubMed ID: 276575
    [No Abstract]   [Full Text] [Related]  

  • 40. The actions of carbenoxolone on enzymes and their relation to its therapeutic effect.
    Roberts NB; Taylor WH
    Scand J Gastroenterol Suppl; 1980; 65():11-7. PubMed ID: 6782651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.